Eps Summary of Penumbra, Inc.

Penumbra, Inc.'s latest annual eps in 2023 was 2.37 USD , up 4580.15% from previous year.
Penumbra, Inc.'s latest quarterly eps in 2024 Q1 was 0.28 USD , down -80.0% from previous quarter.
Penumbra, Inc. reported an annual eps of -0.05 USD in 2022, down -174.19% from previous year.
Penumbra, Inc. reported an annual eps of 0.07 USD in 2021, up 113.2% from previous year.
Penumbra, Inc. reported a quarterly eps of 0.76 USD for 2024 Q3, up 149.03% from previous quarter.
Penumbra, Inc. reported a quarterly eps of -1.55 USD for 2024 Q2, down -653.57% from previous quarter.

Annual Eps Chart of Penumbra, Inc. (2023 - 2012)

Name	Eps	Eps Difference
Abbott Laboratories	3.30 USD	28.182%
Allurion Technologies Inc.	-2.31 USD	202.597%
Artivion, Inc.	-0.75 USD	416.0%
Avanos Medical, Inc.	-1.33 USD	278.195%
Butterfly Network, Inc.	-0.65 USD	464.615%
Butterfly Network, Inc.	-0.65 USD	464.615%
Bio-Rad Laboratories, Inc.	-21.82 USD	110.862%
Boston Scientific Corporation	1.08 USD	-119.444%
Perspective Therapeutics, Inc.	-0.10 USD	2470.0%
CONMED Corporation	2.10 USD	-12.857%
Edwards Lifesciences Corporation	2.31 USD	-2.597%
Paragon 28, Inc.	-0.58 USD	508.621%
Glaukos Corporation	-2.78 USD	185.252%
Globus Medical, Inc.	1.09 USD	-117.431%
Inspire Medical Systems, Inc.	-0.72 USD	429.167%
Integer Holdings Corporation	2.72 USD	12.868%
Medtronic plc	2.77 USD	14.44%
Nevro Corp.	-2.56 USD	192.578%
Owlet, Inc.	-4.53 USD	152.318%
Vicarious Surgical Inc.	-0.49 USD	583.673%
Smith & Nephew plc	0.60 USD	-295.0%
Sonendo, Inc.	-0.65 USD	464.615%
STERIS plc	3.83 USD	38.12%
Stryker Corporation	8.34 USD	71.583%
Vapotherm, Inc.	-9.64 USD	124.585%
Zimmer Biomet Holdings, Inc.	4.91 USD	51.731%